Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors. (Q53136880)

11 May 2018

title

Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors. (English)

1 reference

11 May 2018

1 reference

Yoshiaki Murakami

1

1 reference

11 May 2018

Kenichiro Uemura

2

1 reference

11 May 2018

Takeshi Sudo

3

1 reference

11 May 2018

Yasushi Hashimoto

4

1 reference

11 May 2018

Akira Nakashima

5

1 reference

11 May 2018

Ryutaro Sakabe

6

1 reference

11 May 2018

Hironori Kobayashi

7

1 reference

11 May 2018

Naru Kondo

8

1 reference

11 May 2018

Naoya Nakagawa

9

1 reference

11 May 2018

Taijiro Sueda

10

1 reference

11 May 2018

publication date

1 July 2012

1 reference

11 May 2018

Journal of Hepato-biliary-Pancreatic Sciences

published in

1 reference

11 May 2018

volume

19

1 reference

11 May 2018

issue

4

1 reference

11 May 2018

page(s)

306-313

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00534-011-0498-y

exact match

0 references

cites work

Epidemiology of biliary tract cancers: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Phase II study of S-1 in patients with advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Efficacy and safety of S-1 monotherapy in patients with advanced biliary tract adenocarcinoma: retrospective analysis of 162 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0498-Y

10.1007/S00534-011-0498-Y

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

22270151

1 reference

11 May 2018